Skip to main
ATEC
ATEC logo

Alphatec Hlds (ATEC) Stock Forecast & Price Target

Alphatec Hlds (ATEC) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 57%
Buy 29%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Alphatec Holdings, Inc. reported Q2 2025 revenues of $185.5 million, reflecting a robust year-over-year increase of 27.5% and exceeding consensus estimates. This growth was supported by a 28% rise in surgical volume, driven by both the recruitment of new surgeons and enhanced relationships with existing users. Additionally, the company raised its full-year 2025 revenue guidance to $742 million, representing a projected 21% year-over-year growth, showcasing strong operational momentum.

Bears say

Alphatec Holdings Inc has experienced a decline in its non-GAAP gross margin, which fell to 69.9%, a decrease of 130 basis points year-over-year and 50 basis points sequentially, primarily due to changes in product mix and increased biologic attach rates within its cervical business segment. The company faces additional challenges from the evolving US healthcare landscape, particularly the risk of decreasing reimbursement rates that could adversely affect its revenue. Furthermore, there are concerns regarding the company's ability to meet future expectations, raising further uncertainty about its financial stability and growth prospects.

Alphatec Hlds (ATEC) has been analyzed by 7 analysts, with a consensus rating of Buy. 57% of analysts recommend a Strong Buy, 29% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alphatec Hlds (ATEC) Forecast

Analysts have given Alphatec Hlds (ATEC) a Buy based on their latest research and market trends.

According to 7 analysts, Alphatec Hlds (ATEC) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alphatec Hlds (ATEC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.